Drug intelligence / Profile preview

Souvenaid

Development stage: Unknown
Lead developer: Danone
Modality: Small Molecules
Administration: Oral

Overview

Souvenaid is a medical food designed to support synapse formation and function in individuals with early Alzheimer's disease (AD) and mild cognitive impairment (MCI). It contains a specific multinutrient combination called Fortasyn Connect, which includes uridine monophosphate, choline, phospholipids, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and various vitamins (B6, B12, C, E, and folic acid) and selenium. These components serve as precursors and cofactors for the synthesis of neuronal membranes via the Kennedy pathway. By addressing the early synaptic loss characteristic of AD, Souvenaid aims to maintain or improve cognitive function. It is typically administered as a once-daily 125-mL oral drink and has been evaluated in several clinical trials, including the SOUVENAID, NL-ENIGMA, and LipiDiDiet studies.

Brand names: Souvenaid
Other names: Fortasyn Connect

Beyond the preview

Go deeper on Souvenaid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Souvenaid.

Explore the full profile